semaglutide and cushing's Frontiers Frontiers | Practical therapeutic approach
Description
For the past decade, patients have reported weight loss as a side effect, so clinical trials began to research this effect
Cox proportional hazard models were used to calculate univariate hazard ratios (HR) of baseline variables for GLP1 use
Pregnant patients: Janumet should only be used when needed, with the potential benefits justifying potential risks to the fetus
Look beyond the echofocus on clinical context (underlying malignancy, autoimmune issues) and lab findings to clinch the diagnosis
Science 364:11791184
Support System : A robust support system is instrumental
